Published Online: Saturday, April 1, 2006

Individuals wanting OTC pseudoephedrine (PSE) products are going to be limited as to the number of pills they can buy, and eventually they will have to show identification to purchase these types of medication. The provision is part of President George W. Bush's USA Patriot Act in an attempt to crack down on illegal methamphetamine production.

Beginning this month, federal regulation will limit the sale of PSE to 9 g within a 30-day period. The measure will make exceptions for "single-use" sales—individually packaged PSE products. Identification checks and PSE products located behind the counter will be required by September 30, 2006.

Many retailers already have guidelines in place to limit individuals' access to cold products or to limit their sales. Some drugmakers also have begun making PSE-free cough and cold products.

Latest Articles
A pharmacy robber not only left his fingerprints behind at a pharmacy—he also dropped his wallet containing his identification as he made his escape.
Janssen Research and Development LLC has submitted a new drug application to the FDA for canagliflozin and metformin hydrochloride extended release (Invokamet XR).
Treating chronic pulmonary obstructive disease with both inhaled corticosteroids and long-acting bronchodilators remains controversial, but new evidence suggests that this controller combination could reduce mortality risk.
Beverly Schaefer, RPh, of Katterman's Sand Point Pharmacy in Seattle, Washington, shares some fun tips on how to encourage patients who travel to come to your pharmacy for supplies.
Latest Issues